Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Anesthesia (4)
- Malignant Hyperthermia (4)
- Anesthesia Reactions (1)
- Anesthesia Risks (1)
- Autosomal Dominant Disorder (1)
-
- Cardiac Dysrhythmias (1)
- Critical Care (1)
- Dantrolene (1)
- Hyper Metabolic Disorder (1)
- Hyper-Metabolic (1)
- Hyper-metabolic states (1)
- Hypercapnia (1)
- Local anesthesia toxicity Regional anesthesia lipid emulsion Central nervous system management of LAST airway management (1)
- Medical Emergencies (1)
- Neuromuscular Blockade (1)
- Nurse Anesthesia (1)
- Nursing (1)
- Pathophysiology (1)
- Patient Outcomes (1)
- RyR1 Mutation (1)
- Skeletal Muscle Disorder (1)
Articles 1 - 8 of 8
Full-Text Articles in Medical Sciences
Malignant Hyperthermia, Joel Jackson
Malignant Hyperthermia, Joel Jackson
Nursing Student Class Projects (Formerly MSN)
Malignant hyperthermia (MH) is a hypermetabolic response to succinylcholine or inhaled volatile gases administered during anesthesia and is caused by an autosomal dominant mutation of RYR1 or CACNA1S genes which affect how calcium channels function. The uncontrolled, unopposed calcium release and excitation-contraction coupling results in sustained skeletal muscle contraction resulting in muscle rigidity, hyperthermia, hypercapnia, hypertension, and tachycardia among other less common clinical features. The sequelae of an MH crisis include renal failure, rhabdomyolysis, hyperkalemia, metabolic disturbance and left untreated will result in mortality. All clinicians involved in peri-operative care both in-hospital and out of hospital must be cognizant of …
Malignant Hyperthermia For The Nurse Anesthetist, Victor Clark
Malignant Hyperthermia For The Nurse Anesthetist, Victor Clark
Nursing Student Class Projects (Formerly MSN)
Malignant Hyperthermia (MH) is a rare, autosomal dominant skeletal muscle disorder that can have an insidious onset in susceptible patients exposed to the triggering agents succinylcholine, halothane, desflurane, sevoflurane, and isoflurane. MH can occur in patients who have received anesthesia with these agents in the past (Nagelhout & Plaus, 2018, p 775). Patients with a family history of MH or associated skeletal muscle disorder must be treated as MH-susceptible until proven otherwise. Failure to detect an MH crisis can lead to kidney failure, profound acidosis, coagulopathies, rhabdomyolysis, cardiac dysrhythmias, cardiovascular collapse, and death (Seifert et al., 2015). It is the …
Local Anesthesia Toxicity, Nicole Mccleery
Local Anesthesia Toxicity, Nicole Mccleery
Nursing Student Class Projects (Formerly MSN)
Local anesthesia (LA) provides a way to relieve temporary pain in a small part of the body and has been used for over 100 years (Fencl, 2015). LA also prevents the passage of surgical stimuli into the central nervous system (CNS) making a surgical procedure less painful for the patient (Noble, 2015). According to Noble, “altering the passage of stimuli from smaller diameter neurons in a confined area with lower drug dosages is called LA, such as the injection of LA around a surgical incision” (Noble, 2015, p.325). LA can be used in a variety of settings, such as in …
Malignant Hyperthermia, Aaron Roth
Malignant Hyperthermia, Aaron Roth
Nursing Student Class Projects (Formerly MSN)
Malignant hyperthermia is a rare disease trait and can take place in a variety of settings. If not treated in a timely manner, the consequences will be dire. It is recommended that nurses and other healthcare personnel be properly educated on MH crises. By detecting the signs and symptoms associated with the disease, providers can efficiently remedy the crisis and save patient lives (Seifert, 2014). Since the discovery of dantrolene in 1975 and the advancement of genetics regarding MH, death rates dropped from about 80% to about 5% (Schneiderbanger et al., 2014). Today there is a MH group called the …
Turning Up The Heat On Malignant Hyperthermia, Katie Carroll
Turning Up The Heat On Malignant Hyperthermia, Katie Carroll
Nursing Student Class Projects (Formerly MSN)
Surgeries are common, everyday procedures within the walls of America’s hospitals. According to Orser, Mazer, and Baker (2008), more than forty million patients in North America are given anesthetics annually. One of the major complications of anesthesia is malignant hyperthermia: a hyper-metabolic state that affects skeletal muscles. If left uncontrolled, malignant hyperthermia can cause multiple reactions within the body leading to metabolic and respiratory acidosis, cardiac dysrhythmias, kidney failure, coagulopathy, neurologic injury, and ultimately death (Seifert, Wahr, Pace, Cochrane, & Bagnola 2014). The incidence of this condition is estimated to be 1:15,000 in children and 1:20,000-50,000 in adults (Redmond, 2001). …
Malignant Hyperthermia, Chase Contri
Malignant Hyperthermia, Chase Contri
Nursing Student Class Projects (Formerly MSN)
Although very rare, occurring one out of every 100,000 anesthesia cases, malignant hyperthermia is a hypermetabolic disorder that anesthesia providers screen and interrogate patients prior to every case they are administering anesthesia. Many research studies about anesthesia induced malignant hyperthermia have explored new methods of testing for the genetic susceptibility for malignant hyperthermia and into hospital based protocols when a patient starts to show the signs and symptoms of the metabolic disorder. This new knowledge and understanding has decreased patient mortality of anesthesia induced malignant hyperthermia from eighty percent to five percent over the past three decades (Rosenberg et al, …
Malignant Hyperthermia, Devin Poncsak
Malignant Hyperthermia, Devin Poncsak
Nursing Student Class Projects (Formerly MSN)
A crisis of malignant hyperthermia is a medical emergency, and must be treated immediately with a coordinated, multidisciplinary team response in order to give the patient the highest chance for a successful recovery (Dirksen, Van Wicklin, Mashman, Neiderer, & Merritt, 2013). Malignant hyperthermia is defined by Bandschapp & Girard (2012), as “a disturbance of the skeletal muscle calcium homeostasis, triggered by volatile anaesthetics and depolarizing muscle relaxants.” Once a vulnerable patient is exposed to one of these triggering agents, a pathologic hypermetabolic response ensues, and the patient has a rapid increase in oxygen consumption and expired carbon dioxide, hyperthermia, acidosis, …
Pseudocholinesterase Deficiency, Ross Gerken
Pseudocholinesterase Deficiency, Ross Gerken
Nursing Student Class Projects (Formerly MSN)
Pseudocholinesterase deficiency is a rare genetic or acquired variation in the metabolism of choline esters such as the neuromuscular blockers succinylcholine, mivacurium, and ester local anesthetics. Pseudocholinesterase deficiency genetically is transmitted in an autosomal recessive pattern with the frequency of apnea from a genetic abnormality of pseudocholinesterase between 1:480 and 1:3200 people (Ok et al., 2013). An extended period of neuromuscular blockade results from these medications than what is clinically expected. The signs and symptoms which occur are apnea and paralysis hours longer. This condition is rare but must be known and understood by the clinician in order to provide …